Category: New products
-
Immunotherapy Biotech Gains $108M in New Funds
A company developing more precise immunotherapies for cancer and other diseases is raising $108 million in its second venture funding round.
-
Trial Shows Synthetic Antibody Slows Cognitive Decline
Results show a synthetic antibody reduces the rate of cognitive decline, one of two measures in a clinical trial of patients with mild to moderate Alzheimer’s disease.
-
Trial Shows Wearable Device Monitors Heart Rhythm Indicators
Results from a clinical trial show a device worn on the wrist can measure two key indicators of heart health as accurately as an electrocardiogram.
-
Small Biz Grant to Advance Cancer Chemotherapy Patch
A medical device company is receiving a small business grant from NIH to commercialize a patch that delivers chemotherapy directly to oral tumors.
-
Nasal Spray Shown to Stop Covid-19 Infection, Disease
An antiviral nasal spray is shown in tests with lab mice to prevent infection from SARS-CoV-2 viruses and reduce disease-causing cytokines.
-
AI-Analyzed Liquid Biopsy IDs Early Lung Cancer
A blood test analyzed with algorithms is shown to detect more than 90 percent of early-stage lung cancer cases in people at high risk of the disease.
-
CEPI Funding Covid-19 Variant Vaccine
A biotechnology company is advancing a vaccine to protect against disease from SARS-CoV-2 variants, with new support from the organization CEPI.
-
Biotech Start-Up Gains $90M for Neurodegenerative Diseases
A one year-old biotechnology company developing treatments for diseases of microglia cells in the brain, is raising $90 million in new venture funds.
-
Psychedelic Therapy Company Raises $80M in New Funds
A developer of drugs from psychedelic compounds for mental health conditions is raising $80 million in its second venture funding round.
-
New Company Forms to Ease Scientific Data Operations
A new company spun off from Harvard University aims to simplify data analysis, management, and collaboration for life science researchers.